Sol H. Weiss

Sol H. Weiss, a Shareholder of Anapol Schwartz, is an experienced trial attorney known for his exacting preparation and attention to detail.  A "lawyer's lawyer", he is able to handle the most complex case and still present the facts and law in a way that the judge and jury will understand.

Mr. Weiss concentrates his practice in complex civil litigation including class actions and pharmaceutical cases, medical and other professional malpractice, securities litigation and products liabiliity matters.  He earned his Bachelor's degree from the Pennsylvania State University in 1968 and his law degree from Villanova University School of Law in 1972.  He is licensed to practice in Pennsylvania, as well as being specially admitted to practice in other states.

Mr. Weiss has served in various positions for the Pennsylvania Trial Lawyers Association, and was a member of the Board of the Philadelphia Trial Lawyers Association.  He is currently President of the Eastern Pennsylvania Chapter of the American Board of Trial Advocates.  He is a frequent lecturer on class actions, pharmaceutical liability, civil litigation issues, trial skills and technology in the courtroom.  He has lectured for many professional groups including the Pennsylvania Bar Institute, Mealey's, the Philadelphia Trial Lawyers Association and for private industry.  He is a member of the American, Pennsylvania and Philadelphia Bar Associations and Trial Lawyer Associations.  He is also a member of the Public Investors Arbitration Bar Association (PIABA), which exclusively represents investors in stock fraud and stock loss cases.

Mr. Weiss is an active member of the Board of Consultors of the Villanova University School of Law.  He also served as Director of the Linda Creed Breast Cancer Foundation.

Attorney News & Publications

Dangerous Devices - Consumers should be able to sue, keeping pace with 'Wyeth.' The National Law Journal - May 18, 2009

Wyeth v. Levine: A Monumental Victory for Consumers. Reprinted with permission of the Legal Intelligencer.

When can a drug consumer sue?  The principle of 'preemption' could strengthen FDA. Philly.com -- Nov. 2, 2008

Federal Pre-emption: Another Corporate Bailout - Sol Weiss writes about Federal pre-emption. The Legal Intelligencer -- October 10, 2008

DRUG SUIT PRE-EMPTION No special treatment - Sol Weiss / Special to The National Law Journal The National Law Journal , May 19, 2008

Third Circuit Court of Appeals Decision Removes State Law Recourse for Suicide after Depression Drug: Lead Plaintiff Attorney from Anapol Schwartz Outraged by Federal Infringement of State Police Power

Philly Judge Rules 'No Preemption' In Paxil Case

Protect consumers' right to sue drugmaker. Legal action is a shield against lax regulators.

'Heartburn' Drug Causes Heart Problems, Suit Says

American Home Products Settles
Fen-Phen Cases For $4.8 Million

Foe Becomes Friend For Fen-Phen

In Fen-Phen Trial, The Uninjured Sue for Preventive Maintenance

Judge Approves Fen-Phen
Settlement

Levin Oks Fen-Phen Class Action for Medical Monitoring